Uglime Metformin Tablets 15/850 mg (Pioglitazone Hydrochloride, Metformin Hydrochloride)
Metformin Hydrochloride 850mg · Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication · Combination
Yuyu Pharmaceutical Co., Ltd.
MFDS item code 201906555 · Approved 2019.09.19
This product's status changed to Expired on 2024.09.19. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improvement of blood glucose control in type 2 diabetes mellitus
This medication is used to help regulate blood sugar in patients with insulin-independent diabetes, specifically type 2 diabetes. It can be administered particularly when adequate blood sugar control is not achieved with monotherapy of Metformin or Pioglitazone. Additionally, this medication can be used instead of the combination therapy of Pioglitazone and Metformin. For the management of type 2 diabetes, dietary counseling, weight reduction, and regular exercise are essential, and these lifestyle modifications are crucial for enhancing the effectiveness of the pharmacotherapy. This medication aids in improving blood sugar control as an adjunct to dietary and exercise therapy.
For the treatment of patients with type 2 diabetes mellitus, the dose of this medicine should be individualized based on efficacy and tolerability, without exceeding the maximum dose of each component: pioglitazone 30mg and metformin 2500mg. The initial dose of this medicine should be based on the patient's current treatment regimen. 1. Patients whose blood glucose is not adequately controlled with pioglitazone or metformin monotherapy: The dose should be based on the current dose of metformin or pioglitazone. Start with 1 tablet once daily and gradually adjust the dose after assessing the adequacy of the treatment response. 2. Patients switching from combination therapy with pioglitazone and metformin: Patients switching from combination therapy with pioglitazone and metformin to this medicine may start at the doses of pioglitazone and metformin they were previously taking. No studies have been conducted to evaluate the safety and efficacy of switching from another oral antihyperglycemic agent to this medicine. Any change in the treatment regimen for type 2 diabetes mellitus may alter glycemic control; therefore, caution should be exercised and appropriate monitoring should be performed. 3. Patients with renal impairment: All dose adjustments should be based on careful assessment of renal function. In general, older adults, debilitated patients, and malnourished patients should not be titrated up to the maximum dose of this medicine. After administering this medicine to a patient or increasing the dose, monitor carefully for adverse reactions associated with fluid retention. This medicine should generally be administered in divided doses with meals to reduce gastrointestinal adverse reactions caused by metformin. Allow sufficient time to assess the adequacy of the treatment response. Ideally, response to treatment should be assessed using glycated hemoglobin (HbA1C), which is a better indicator of long-term glycemic control than fasting plasma glucose (FPG). HbA1c reflects blood glucose levels over the preceding 2 - 3 months. In clinical use of this medicine, if glycemic control measured by FPG does not worsen, administration for an appropriate period (8-12 weeks) is recommended to assess changes in HbA1C.
This medication helps regulate blood sugar. However, it should not be used in patients with impaired kidney function or severe heart disease. In particular, this medication can cause a serious side effect called lactic acidosis, which is a dangerous condition where lactic acid accumulates excessively in the body. Lactic acidosis is very rare but can be fatal, so if symptoms such as sudden shortness of breath, muscle pain, fatigue, or abdominal pain appear, one should consult a physician immediately. Additionally, this medication should not be taken by patients with liver dysfunction or individuals who consume alcohol excessively. This medication may worsen heart failure, so caution is necessary for patients with heart failure. During treatment, it is essential to carefully monitor for symptoms of heart failure such as weight gain, swelling, or shortness of breath. This medication is not recommended for women who are pregnant or breastfeeding. Also, while using this medication, regular monitoring of blood sugar, liver function, kidney function, and blood tests is necessary. Overdosing on this medication may lead to hypoglycemia or severe side effects; therefore, it is crucial to adhere to the prescribed dosage. Before any sudden surgery or diagnostic tests using contrast agents, one should consult a physician to temporarily discontinue the medication. Additionally, there may be other medications that interact with this medication, so inform your doctor or pharmacist if you are taking any other drugs. Lastly, this medication's safety has not been established in children, and for the elderly, dosage adjustment and monitoring are required due to potential declines in kidney function.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so ensure that it is stored in a sealed container. It is best to maintain the storage temperature between 1 to 30 degrees Celsius. Proper storage will help maintain the medication's efficacy over time.
White to pale gray oblong film-coated tablets
30 tablets/PTP [(10 tablets/PTP * 3)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Metformin Hydrochloride 850mg · Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication · Combination
Yuyu Pharmaceutical Co., Ltd.
Pioglitazone Hydrochloride 16.53mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Celltrion Pharmaceutical Co., Ltd.
CombinationMetformin Hydrochloride 850mg · Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication · Combination
Genewon Science Co., Ltd.
CombinationMetformin Hydrochloride 850mg · Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication · Combination
Dalim Biotech Co., Ltd.
CombinationPioglitazone Hydrochloride 16.53mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Kyungdong Pharmaceutical Co., Ltd.
Metformin Hydrochloride · Pioglitazone Hydrochloride
Prescription medication · Combination
Nexpam Korea Co., Ltd.
CombinationPioglitazone Hydrochloride 16.53mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Korea Prime Pharmaceutical Co., Ltd.
CombinationMetformin Hydrochloride 850mg · Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication · Combination
Ilhwa Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.